pharmaphorum January 6, 2022

We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, including the potential of digital solutions to diagnose disease earlier, using digital therapeutics or preventive digital solutions more efficiently, and making use of technologies that result in accelerated drug discovery and development.

Why are you attending the virtual J.P. Morgan 2022?

The J.P. Morgan week has historically brought large flocks of investors, industry and companies raising funding rounds to San Francisco every January. This will be the second year in a row that the event will be organised virtually, due to COVID. Although we really miss meeting our colleagues in real life on the buzzing streets and meeting rooms of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Interview / Q&A, Technology, Trends
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Delivering the Right Approach for Virtual Primary Care: 3 Key Insights
Q&A: Bring your own device: How patients own tech is being used in clinical trials

Share This Article